Susanne Posel ,Chief Editor Occupy Corporatism | The US Independent
March 8, 2014
Cediic Garland, professor at the Department of Family and Preventative Medicine (DFPM) collaborated with researchers at the University of California at San Diego (UCSD) to conduct a study on vitamin D and its effects on breast cancer.
The findings are staggering.
According to the study, breast cancer patients who had vitamin D in their bloodstream were 2times as likely to survive the cancer.
Garland explained: “Vitamin D metabolites increase communication between cells by switching on a protein that blocks aggressive cell division. As long as vitamin D receptors are present tumor growth is prevented and kept from expanding its blood supply. Vitamin D receptors are not lost until a tumor is very advanced. This is the reason for better survival in patients whose vitamin D blood levels are high.”
Researchers analyzed data from 5 previous studies wherein 25-hydroxyvitamin D was used on breast cancer patients over the course of 9 years.
Garland said: “There is no compelling reason to wait for further studies to incorporate vitamin D supplements into standard care regimens since a safe dose of vitamin D needed to achieve high serum levels above 30 nanograms per milliliter has already been established.”